This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MSON Misonix (MSON) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Misonix Stock (NASDAQ:MSON) 30 days 90 days 365 days Advanced Chart Get Misonix alerts:Sign Up Key Stats Today's Range$26.54▼$26.5450-Day Range$24.89▼$26.5452-Week Range$11.04▼$26.99Volume2 shsAverage Volume60,302 shsMarket Capitalization$462.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY. Read More Receive MSON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter. Email Address MSON Stock News HeadlinesHow Ryan Mason's West Brom vision is already shaping upJuly 13 at 9:24 PM | msn.comNagpur Freemasons hold historic Lodge Meeting at Umling La, world’s highest motorable roadJuly 13 at 9:24 PM | msn.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 14 at 2:00 AM | Brownstone Research (Ad)The Devon pub that went from zero to Michelin star in six monthsJuly 12 at 8:08 AM | msn.com'Fascinating access to Mason's session'July 10, 2025 | msn.comMississippi State baseball, Brian O'Connor land George Mason's Andrew Raymond in transfer portalJuly 10, 2025 | msn.comCemetery of mutiny, masons, memory and more!July 6, 2025 | msn.comMeet the retired detective appointed head of County Durham FreemasonsJuly 6, 2025 | msn.comSee More Headlines MSON Stock Analysis - Frequently Asked Questions How were Misonix's earnings last quarter? Misonix, Inc. (NASDAQ:MSON) announced its quarterly earnings data on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%. What other stocks do shareholders of Misonix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Misonix investors own include EDAP TMS (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Fulgent Genetics (FLGT), Ampio Pharmaceuticals (AMPE), Sociedad Quimica y Minera (SQM) and Sorrento Therapeutics (SRNE). Company Calendar Last Earnings9/02/2021Today7/14/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Laboratory Apparatus & Furniture Sub-IndustryN/A Current SymbolNASDAQ:MSON CIK880432 Webwww.misonix.com Phone(631) 694-9555Fax631-694-9412Employees254Year Founded1959Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.47 million Net Margins-19.55% Pretax Margin-19.37% Return on Equity-10.36% Return on Assets-7.29% Debt Debt-to-Equity Ratio0.29 Current Ratio2.61 Quick Ratio1.92 Sales & Book Value Annual Sales$74.02 million Price / Sales6.24 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book3.42Miscellaneous Outstanding Shares17,410,000Free Float11,893,000Market Cap$462.06 million OptionableNot Optionable Beta1.36 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:MSON) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Misonix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Misonix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.